Labcorp announces q4 earnings per share $2.32

Labcorp announces 2019 fourth quarter and full year results and provides 2020 guidance.q4 earnings per share $2.32.q4 earnings per share estimate $2.80 -- refinitiv ibes data.sees fy 2020 adjusted earnings per share $11.75 to $12.15.q4 adjusted earnings per share $2.86.labcorp sees 2020 revenue growth of 4.0% to 6.0%.labcorp- qtrly revenue of $3.0 billion, up 6% over 2018.labcorp sees 2020 free cash flow of $950 million to $1.05 billion.labcorp - labcorp diagnostics revenue for quarter was $1.76 billion, an increase of 3.7% over $1.69 billion in q4 of 2018.labcorp - covance drug development revenue for quarter was $1.20 billion, an increase of 9.3% over $1.10 billion in q4 of 2018.labcorp sees 2020 revenue growth in labcorp diagnostics of 0.5% to 2.5%.labcorp sees 2020 revenue growth in covance drug development of 7.0% to 9.5%.q4 revenue view $2.93 billion -- refinitiv ibes data.fy2020 earnings per share view $11.98 -- refinitiv ibes data.
LH Ratings Summary
LH Quant Ranking